Posted by admin on May 5th, 2022
Proto Labs, Inc. (NYSE:PRLB – Get Rating) was the recipient of a significant decrease in short interest in the month of April. As of April 15th, there was short interest totalling 886,100 shares, a decrease of 21.6% from the March 31st total of 1,130,000 shares. Approximately 3.3% of the shares of the stock are short sold. Based on an average trading volume of 239,800 shares, the short-interest ratio is presently 3.7 days.
Shares of PRLB stock opened at $45.78 on Thursday. Proto Labs has a 1 year low of $41.73 and a 1 year high of $106.06. The stock’s 50 day simple moving average is $50.21 and its two-hundred day simple moving average is $53.37. The company has a market cap of $1.26 billion, a PE ratio of 38.15 and a beta of 1.43.
Proto Labs (NYSE:PRLB – Get Rating) last issued its quarterly earnings data on Friday, February 11th. The industrial products company reported $0.43 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.16 by $0.27. Proto Labs had a return on equity of 4.05% and a net margin of 6.84%. The business had revenue of $123.60 million for the quarter, compared to the consensus estimate of $117.91 million. During the same period in the prior year, the business posted $0.36 earnings per share. The company’s quarterly revenue was up 17.5% compared to the same quarter last year. Equities research analysts expect that Proto Labs will post 0.51 earnings per share for the current fiscal year.
PRLB has been the topic of a number of research analyst reports. StockNews.com initiated coverage on Proto Labs in a research report on Thursday, March 31st. They issued a “hold” rating on the stock. Zacks Investment Research upgraded Proto Labs from a “sell” rating to a “hold” rating in a research report on Wednesday, March 2nd. Five research analysts have rated the stock with a hold rating, According to MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $74.50.
A number of hedge funds have recently modified their holdings of the business. Amundi Pioneer Asset Management Inc. raised its holdings in shares of Proto Labs by 34.0% in the first quarter. Amundi Pioneer Asset Management Inc. now owns 166,743 shares of the industrial products company’s stock worth $17,531,000 after buying an additional 42,323 shares during the period. Morgan Stanley raised its holdings in shares of Proto Labs by 47.9% in the second quarter. Morgan Stanley now owns 370,382 shares of the industrial products company’s stock worth $34,001,000 after buying an additional 120,022 shares during the period. Victory Capital Management Inc. raised its holdings in shares of Proto Labs by 995.6% in the third quarter. Victory Capital Management Inc. now owns 29,155 shares of the industrial products company’s stock worth $1,942,000 after buying an additional 26,494 shares during the period. Truist Financial Corp purchased a new stake in shares of Proto Labs in the third quarter worth approximately $326,000. Finally, Russell Investments Group Ltd. raised its holdings in shares of Proto Labs by 67.4% in the third quarter. Russell Investments Group Ltd. now owns 17,228 shares of the industrial products company’s stock worth $1,147,000 after buying an additional 6,936 shares during the period. Institutional investors and hedge funds own 93.35% of the company’s stock.
About Proto Labs (Get Rating)
Proto Labs, Inc, together with its subsidiaries, operates as an e-commerce driven digital manufacturer of custom prototypes and on-demand production parts in the worldwide. The company offers injection molding; computer numerical control machining; three-dimensional (3D) printing, which include stereolithography, selective laser sintering, direct metal laser sintering, multi jet fusion, polyjet, and carbon DLS processes; and sheet metal fabrication products, including quick-turn and e-commerce-enabled custom sheet metal parts.
Receive News & Ratings for Proto Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs and related companies with MarketBeat.com's FREE daily email newsletter.
Short Interest in Under Armour, Inc. (NYSE:UA) Drops By 21.7%
B. Riley Lowers Lumentum (NASDAQ:LITE) Price Target to $119.00